View Item 

Show simple item record

GABA involvement in memory consolidation: Evidence from posttrial amino-oxyacetic acid

dc.contributor.authorLiebler, L.en_US
dc.contributor.authorKatz, Richard J.en_US
dc.date.accessioned2006-09-11T17:44:16Z
dc.date.available2006-09-11T17:44:16Z
dc.date.issued1978-01en_US
dc.identifier.citationKatz, R. J.; Liebler, L.; (1978). "GABA involvement in memory consolidation: Evidence from posttrial amino-oxyacetic acid." Psychopharmacology 56(2): 191-193. <http://hdl.handle.net/2027.42/46400>en_US
dc.identifier.issn0033-3158en_US
dc.identifier.issn1432-2072en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46400
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=417370&dopt=citationen_US
dc.description.abstractIn order to assess the possible effects of central GABA activation on the consolidation of shock avoidance, the GABA-T inhibitor amino-oxyacetic acid (AOAA) was administered posttrial to adult male rats. Learning was assessed over nine widely spaced sessions of 20 trials each. AOAA-treated animals showed learning within sessions and a lack of consolidation across sessions. Controls, on the other hand, showed learning both within and across sessions. This evidence agrees with previous reports suggesting GABA involvement in memory processes.en_US
dc.format.extent280188 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherConsolidationen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherAOAAen_US
dc.subject.otherGABAen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherPsychiatryen_US
dc.subject.otherMemoryen_US
dc.titleGABA involvement in memory consolidation: Evidence from posttrial amino-oxyacetic aciden_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumMental Health Research Institute, Department of Psychiatry, University of Michigan Medical Center, 48109, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumMental Health Research Institute, Department of Psychiatry, University of Michigan Medical Center, 48109, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid417370en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46400/1/213_2004_Article_BF00431848.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00431848en_US
dc.identifier.sourcePsychopharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
213_2004_Article_BF00431848.pdf
Size:
273.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.